Motil KJ, Matthews DE, Bier DM, Burke JF, Munro HN, Young VR
Absolute contraindications: Known allergy to either peptide or its components Active cancer (insufficient safety data) Pregnancy or breastfeeding (insufficient safety data) Severe immunocompromise (theoretical concern) Relative contraindications (require careful consideration): History of cancer (consult a medical advisor) Major cardiac disease (monitor closely) Severe liver or kidney disease (may affect clearance) Active infections (wait until resolved) Bleeding disorders (monitor injection sites carefully) Special populations: Elderly subjects: usually well tolerated, no dose adjustment needed Subjects with multiple conditions: enhanced monitoring recommended Those on multiple medications: review for possible interactions Drug Interactions The peptides have minimal documented drug interactions
With the 50 mg vial reconstituted in 1 ml, the concentration is fixed, so your unit count maps directly to milligrams
However, the total number of attacks was decreased in intervention group (133)
Guidelines for the Safe Preparation of Sterile Compounds: Results of the ISMP Sterile Preparation Compounding Safety Summit of October 2011
Pharmacokinetics L-Carnitine is very easily soluble in water, and can be entirely absorbed by the human body when consumed through food